| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;69:898-903
© 2000 The Society of Thoracic Surgeons
a Department of Thoracic Surgery, Marie Lannelongue Hospital, Le Plessis Robinson, France
Address reprint requests to Dr Regnard, Service de Chirurgie Thoracique, Centre Chirurgical Marie Lannelongue, 133 Ave de la Résistance, Le Plessis Robinson, 92350, France
Background. Surgery for pleuropulmonary aspergilloma is reputed to be risky. We reviewed our results, focusing attention on the postoperative complications.
Methods. During a 20-year period, 87 patients were operated on for pulmonary (86) or pleural (3) aspergillomas. Seventy-two percent of patients were complaining of hemoptysis. Eighty-nine resections were performed because there were two bilateral cases. Seventy percent of aspergillomas had developed in cavitation sequelaes from tuberculosis disease. Thirty-four patients had severe respiratory insufficiency that allowed us to perform only lobectomy (18), segmentectomy (2), or cavernostomy (14).
Results. Thirty-seven lobectomies (five with associated segmentectomies), two bilobectomies, 21 segmentectomies, 10 pneumonectomies, and 17 cavernostomies were performed. Total blood loss exceeded 1,500 mL in 14 cases, and 71% of patients required blood transfusion. There were five postoperative deaths (5.7%), related to respiratory failure (2), infectious complication (1), pulmonary embolus (1), and cardiorythmic disorder (1). Incomplete reexpansions were frequently seen in patients undergoing lobectomies or segmentectomies. No death or major complications occurred in asymptomatic patients. During follow-up, none of the patients had recurrent hemoptysis.
Conclusions. Surgical resection of aspergilloma is effective in preventing recurrence of hemoptysis. It has low risk in asymptomatic patients and in the absence of underlying pulmonary disease. Incomplete reexpansion is frequent after lobectomy and segmentectomy, especially when there is underlying lung disease. Cavernostomy is an effective treatment in high-risk patients. Long-term prognosis is mainly dependent on the general condition of patients.
This article has been cited by other articles:
|
|
 |
|
  L. B. Gadkowski and J. E. Stout Cavitary Pulmonary Disease Clin. Microbiol. Rev., April 1, 2008; 21(2): 305 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Scholten, V. Kulkarni, and J. B. Brodsky Isolation of the Right Upper-Lobe with a Left-Sided Double-Lumen Tube After Left-Pneumonectomy Anesth. Analg., August 1, 2007; 105(2): 330 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Camuset, H. Nunes, M.-C. Dombret, A. Bergeron, P. Henno, B. Philippe, G. Dauriat, G. Mangiapan, A. Rabbat, and J. Cadranel Treatment of Chronic Pulmonary Aspergillosis by Voriconazole in Nonimmunocompromised Patients Chest, May 1, 2007; 131(5): 1435 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Demir, M. Z Gunluoglu, A. Turna, H. V Kara, and S. I Dincer Analysis of Surgical Treatment for Pulmonary Aspergilloma Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 407 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shiraishi, N. Katsuragi, Y. Nakajima, M. Hashizume, N. Takahashi, and Y. Miyasaka Pneumonectomy for complex aspergilloma: is it still dangerous? Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 9 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Akbari, P. K. Varma, P. K. Neema, M. U. Menon, and K. S. Neelakandhan Clinical Profile and Surgical Outcome for Pulmonary Aspergilloma: A Single Center Experience Ann. Thorac. Surg., September 1, 2005; 80(3): 1067 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gebitekin, A. S. Bayram, and S. Akin Complex pulmonary aspergilloma treated with single stage cavernostomy and myoplasty Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 737 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C Kurul, S. Demircan, U. Yazici, T. Altinok, S. Topcu, and M. Unlu Surgical Management of Pulmonary Aspergilloma Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 320 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sagawa, T. Sakuma, T. Isobe, M. Sugita, Y. Waseda, H. Morinaga, and K. Iuchi Cavernoscopic Removal of a Fungus Ball for Pulmonary Complex Aspergilloma Ann. Thorac. Surg., November 1, 2004; 78(5): 1846 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rergkliang, A. Chetpaophan, V. Chittithavorn, and P. Vasinanukorn Surgical Management of Pulmonary Cavity Associated with Fungus Ball Asian Cardiovasc Thorac Ann, September 1, 2004; 12(3): 246 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Pepeljnjak, Z Slobodnjak, M Segvic, M Peraica, and M Pavlovic The ability of fungal isolates from human lung aspergilloma to produce mycotoxins Human and Experimental Toxicology, January 1, 2004; 23(1): 15 - 19. [Abstract] [PDF]
|
|
|
|
|
|
A. O. Soubani and P. H. Chandrasekar The Clinical Spectrum of Pulmonary Aspergillosis* Chest, June 1, 2002; 121(6): 1988 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kato, I. Usami, H. Morita, M. Goto, M. Hosoda, A. Nakamura, and S. Shima Chronic Necrotizing Pulmonary Aspergillosis in Pneumoconiosis : Clinical and Radiologic Findings in 10 Patients Chest, January 1, 2002; 121(1): 118 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Al-Kattan, M. Ashour, W. Hajjar, M. Salah El Din, M. Fouda, and A. Al Bakry Surgery for pulmonary aspergilloma in post-tuberculous vs. immuno-compromised patients Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 728 - 733. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
